Livedoid vasculitis - Livedoid Vaskulit
Livedoid Vaskulit (Livedoid vasculitis) är en kronisk hudsjukdom som främst drabbar unga och medelålders kvinnor. En akronym som används för att beskriva dess egenskaper är "Pinful purpuric ulcers with reticular pattern of the lower extremities" (LILA). Tillståndet är förknippat med flera sjukdomar, bland annat kronisk venös hypertoni och åderbråck.
☆ I Stiftung Warentest-resultaten 2022 från Tyskland var konsumentnöjdheten med ModelDerm bara något lägre än med betalda telemedicinkonsultationer.
Det kan åtföljas av smärta.
relevance score : -100.0%
ReferencesLivedoid vasculopathy är ett sällsynt hudtillstånd som kännetecknas av smärtsamma sår som återkommer kontinuerligt på underbenen.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy (LV) is a rare thrombotic vasculopathy of the dermis characterized by painful, relapsing ulcers over the lower extremities. Diagnosis is challenging due to the overlap in clinical appearance and nomenclature with other skin disorders. Treatment selection is complicated by poor understanding of the pathogenesis of LV and lack of robust clinical trials evaluating therapy efficacy. The terminology and pathophysiology of LV are reviewed here, along with its epidemiology, clinical and histologic features, and treatment options. A diagnostic pathway is suggested to guide providers in evaluating for comorbidities, referring to appropriate specialists, and choosing from the available classes of therapy.
Livedoid vasculopathy är en sällsynt hudsjukdom som ger återkommande sår på underbenen och lämnar bleka ärr, så kallade atrophie blanche. Även om den exakta orsaken fortfarande är oklar tror man att ökad blodkoagulering (hypercoagulability) är huvudfaktorn, medan inflammation spelar en sekundär roll. Faktorer som bidrar till koaguleringen inkluderar: deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. I biopsier visar tillståndet blodproppar i kärlen, förtjockning av kärlväggarna och ärrbildning. Behandlingen kräver ett mångsidigt tillvägagångssätt som fokuserar på att förebygga blodproppar med blodplättsdämpande läkemedel, blodförtunnande medel och fibrinolytisk terapi. Olika läkemedel kan användas för denna hudåkomma, exempelvis colchicine och hydroxychloroquine, vasodilators och immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy is a rare skin condition that causes recurring ulcers on the lower legs, leaving behind pale scars known as atrophie blanche. While the exact cause is still unclear, it's believed that increased blood clotting (hypercoagulability) is the main factor, with inflammation playing a secondary role. Factors contributing to clotting include as follows - deficiencies in proteins C and S, genetic mutations like factor V Leiden, antithrombin III deficiency, prothrombin gene mutations, high levels of homocysteine. In biopsies, the condition shows blood clots inside vessels, thickening of vessel walls, and scarring. Treatment involves a multi-pronged approach focusing on preventing blood clots with medications like anti-platelet drugs, blood thinners, and fibrinolytic therapy. Various drugs can be used for this skin condition - colchicine and hydroxychloroquine, vasodilators, immunosuppressants.
Livedoid vasculopathy är ett sällsynt tillstånd där skador uppstår på båda benen. Bildandet av blodproppar i små blodkärl tros bero på ökad koagulering och minskad proppnedbrytning, samt på skador i kärlfodret. Tillståndet är vanligare hos kvinnor, särskilt i åldern 15–50 år. Att sluta röka, ta hand om såren och använda blodförtunnande samt trombocythämmande läkemedel har visat sig vara effektivt.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
Livedoid vasculopathy is a rare vasculopathy that is typically characterized by bilateral lower limb lesions. Increased thrombotic activity and decreased fibrinolytic activity along with endothelial damage are believed to be the cause of thrombus formation in the capillary vasculature. It is 3 times more common in females than in males, especially in patients between the ages of 15 to 50 years. There is no definite first-line treatment, but general measures like smoking cessation, wound care, and pharmacological measures like anticoagulants and antiplatelets have shown good results.
